ArticleThe World Allergy Organization journal2026
Forecasting seasonal allergic rhinitis through integrated analysis of social media and online drug sales data.
Article in The World Allergy Organization journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Allergic rhinitis (AR) is a highly prevalent, seasonally variable disease that poses a growing public health challenge. Conventional surveillance based on clinic visits and surveys is slow and may miss self-medicating patients. Integrating environmental monitoring with digital traces such as search queries and online drug purchases may provide more timely insight into allergen exposure, symptom awareness, and medication demand. Methods: We analyzed daily data for urban Beijing from March 1, 2022 to October 15, 2024, including pollen concentration (grains per 1000 mm Results: All 3 series exhibited pronounced and recurrent seasonal patterns, with Baidu search activity rising in close temporal alignment with pollen peaks and antihistamine purchases typically lagging by 1-2 days. Pre-whitened cross-correlations remained moderate and statistically significant around lag 0, indicating genuine contemporaneous associations after removing the shared seasonal component. Mediation analysis showed that pollen concentration had a significant total effect on antihistamine purchase rates (β = 0.34, 95% CI [0.13, 0.54]), of which approximately 47% was transmitted indirectly via the Baidu Index (indirect β = 0.16, 95% CI [0.08, 0.25]). The ARIMAX (1,1,1) model integrating both pollen and Baidu Index achieved the best forecasting performance (1-day RMSE = 3.80, MAPE = 7.68%, PCC = 0.89) and consistently outperformed single-predictor models and the random-walk benchmark across all horizons. Conclusion: Pollen exposure influences antihistamine demand both directly and indirectly through public information-seeking behavior captured by the Baidu Index, and integrating environmental and digital data enables timely surveillance of seasonal allergic-rhinitis-related medication use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.